Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT04881604
Eligibility Criteria:
Inclusion Criteria:
1\. Women
1. Age over 18 years
2. Undergo surgical treatment for breast cancer
3. Diagnosed with lymphedema in the upper limb stabilized for a period ≥6 months
4. Indicated the second phase of compressive therapy / treatment of lymphedema
Exclusion Criteria:
1\. Women with:
1. Bilateral lymphedema;
2. Lymphedema since the preoperative period;
3. Presence of phlogistic signs in the limb with lymphedema;
4. Treatment of lymphedema (phase 1) in the last three months;
5. Previous history of allergic reaction to the material used for compressive therapy;
6. Active regional or remote disease;
7. In chemotherapy or radiation therapy;
8. Functional changes in the upper limbs prior to the diagnosis of breast cancer;
9. Heart disease and decompensated systemic arterial hypertension; psychiatric, mental, neurological disorders or cognitive deficits that make it impossible to answer the questionnaires.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04881604
Study Brief:
Protocol Section:
NCT04881604